The ACCP PBRN is seeking to collaborate with an investigator interested in co-developing and leading an economic evaluation of the MEDAP Study. The objective of the Medication Error Detection, Amelioration, and Prevention (MEDAP) Study was to describe the medication errors detected and the clinical pharmacist interventions implemented to resolve errors from a broad sampling of clinical pharmacy practice sites and settings throughout the United States. The study recruited 71 clinical pharmacists and documented 782 complete eligible reports of medication errors. Contained within each report was information specific to each medication error, including the name of the medication involved, the type of error and the reasons it occurred, the degree of harm to the patient, pharmacist recommendations and interventions, and the outcome of the medication error, if known. The manuscript is under development.

There is a lack of updated information regarding the economic impact of medication errors in the United States. Therefore, the ACCP PBRN is proud to announce this unique RFP for a qualified ACCP member applicant. The economic evaluation will be developed in collaboration with the principal investigator of the MEDAP Study (Grace Kuo) and the co-investigators (Jacque Marinac and Daniel Touchette). The expected output will be a manuscript published in Pharmacotherapy.

For more information about the MEDAP Study, as well as a full application packet, please e-mail Rachel Chennault ([email protected]) at the ACCP PBRN.